BORJE S ANDERSSON to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications BORJE S ANDERSSON has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.284
-
Autologous engineered T cell receptor therapy in advanced cancer. Hum Vaccin Immunother. 2023 Dec 15; 19(3):2290356.
Score: 0.137
-
Viral-specific T-cell response in hemorrhagic cystitis after haploidentical donor stem cell transplantation. Transpl Infect Dis. 2017 Dec; 19(6).
Score: 0.089
-
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer. Cancer Immunol Res. 2023 07 05; 11(7):925-945.
Score: 0.033
-
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients. Cytotherapy. 1999; 1(5):401-7.
Score: 0.024